Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
Recruiting · NCT04566991 · Registry updated 2025-11-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Recruiting | Phase 2 | 2025-11-28 | NCT04566991 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aditya S. Pandey, MD | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Michigan | Ann Arbor | United States | 538 |